Response of HIV positive patients to the long-term salvage therapy by lopinavir/ritonavir

Article ID	Journal	Published Year	Pages	File Type
9268744	Journal of Clinical Virology	2005	5 Pages	PDF

Abstract

The results of LPV/r salvage therapy were encouraging. About 47% of patients from our study achieved stable suppression of viral replication for 31 months on average. LPV/r proved to be potent inhibitor despite unfavourable prognosis.

Keywords

LPV SQV IDV LPV/r Indinavir NFV NVP RTV NRTI NNRTI ABC EFV AZT 3TC RTI PBMC RT-PCR DDI HAART ddC Efavirenz Abacavir Reverse transcriptase highly active antiretroviral therapy Salvage therapy Ritonavir Saquinavir Peripheral blood mononuclear cell Lopinavir Drug resistance Nucleoside reverse transcriptase inhibitors Non-Nucleoside Reverse Transcriptase Inhibitors Protease inhibitors Protease inhibitor Nelfinavir reverse transcriptase polymerase chain reaction HIV-1 Protease

Related Topics

Life Sciences Immunology and Microbiology Applied Microbiology and Biotechnology

Preview

Response of HIV positive patients to the long-term salvage therapy by lopinavir/ritonavir

Authors

Jana VáclavÃková, Ladislav Machala, Marie StaÅková, Marek Linka, Marie BrÅ¯Äková, Jana Vandasová, Jan Konvalinka,